CYTOTOXICITY AND ANTITUMOR PROPERTIES OF THE ABNORMAL NUCLEOSIDE TUBERCIDIN (NSC-56408).
D000818:Animals; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D002286:Carcinoma, Ehrlich Tumor; D002455:Cell Division; D004285:Dogs; D006066:Gonads; D007275:Injections, Intravenous; D007668:Kidney; D008099:Liver; D008168:Lung; D051379:Mice; D009369:Neoplasms; D009705:Nucleosides; D010179:Pancreas; D051381:Rats; D012106:Research; D012510:Sarcoma 180; D012513:Sarcoma, Experimental; D012517:Sarcoma, Yoshida; D013045:Species Specificity; D014116:Toxicology; D014372:Tubercidin
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D009705:Nucleosides; D014372:Tubercidin
ANTIBIOTICS; ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR; CELL DIVISION; DOGS; EXPERIMENTAL LAB STUDY; GONADS; INJECTIONS, INTRAVENOUS; KIDNEY; LIVER; LUNG; MICE; NUCLEOSIDES; PANCREAS; RATS; SARCOMA 180, CROCKER; SARCOMA, JENSEN; SARCOMA, YOSHIDA; SPECIES SPECIFICITY; TOXICOLOGIC REPORT